SOX1 and nasopharyngeal carcinoma: In a study by Guan et al. [7] SOX1 was shown to interact with β-Catenin in the Wnt signaling pathway and reverse the malignant biological behavior of nasopharyngeal carcinoma by inhibiting the activation of β-Catenin.